Karyopharm reports third quarter 2020 financial results and highlights recent company progress

Newton, mass., nov. 2, 2020 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the quarter ended september 30, 2020. in addition, karyopharm highlighted select...
KPTI Ratings Summary
KPTI Quant Ranking